Skip to content

Clinical trials

Withdrawn Diabetes Mellitus, Type 2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Withdrawn Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20082
20092
20102
20112
20123
20137
20144
20154
20164
20174
20185
20193
20203
202111
20223
20235
20243
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Intarcia Therapeutics3
Novo Nordisk A/S3
Boston Medical Center2
Cedars-Sinai Medical Center2
Emory University2
GlaxoSmithKline2
Kaiser Permanente2
Medtronic MiniMed, Inc.2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 282
Diabetes Mellitus21
Obesity8
Diabetes Mellitus, Type 17
Insulin Resistance7
Hypertension5
Cardiovascular Diseases3
Major Depressive Disorder3
Diabetic Foot2
Glucose Intolerance2

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.